September 19, 2024
Posterior tibial tendinopathy associated with matrix metalloproteinase 13 promoter genotype and haplotype.

Posterior tibial tendinopathy associated with matrix metalloproteinase 13 promoter genotype and haplotype.

The posterior tibial tendon (PTT) is very vulnerable and insufficiency was recognized as the major cause of adult acquired flat foot. Some patients have no predisposing cause clinically recognized, showing that the characteristics of the individual plays an important role in tendinopathy. This study investigated whether genetic variants in matrix metalloproteinase (MMP) are associated with dysfunction PTT.

METHOD
One hundred women who served dysfunction PTT, the histopathological examination of the tendons and magnetic resonance imaging (MRI) confirms tendinopathy, and 100 women without symptoms who PPT intact as assessed by MRI and a control group, were evaluated for MMP-13 G-77 A> > G (rs2252070) polymorphism, individually and in haplotypes, as well as in combination with MMP-1 G-519 A >> G (rs1144393), MMP-1 G-1607 G >> GG (rs1799750) and MMP-8 G. 799 C >> T (rs11225395) polymorphism with PTT dysfunction.

RESULTS
The frequency of allele A (MMP-13 G-77 A >> G (rs2252070) polymorphism) was significantly higher in case group (76% and 61%, respectively; p = 0.010, odds ratio = 2.02; 95 % confidence interval = 1.32 to 3.12). The distribution of genotypes also differed significantly between groups (p = 0.001, odds ratio = 2.82; 95% confidence interval = 1.58 to 5.02). global haplotype analysis showed a significant difference between the two groups.

CONCLUSION
In conclusion, these findings suggest that MMP-13 G-77 A >> G (rs2252070) polymorphism individually, as well as haplotypes MMP-1 G-519 A >> G (rs1144393), MMP-1 g.- 1607 G> > GG (rs1799750) and MMP-8 G-799 C >> T (rs11225395), can cause dysfunction PTT.

NanoSim: sequence based nanopore reading simulator statistical characterization.

The Minion sequencing instrument of Oxford Nanopore Technologies (ONT) produces long read length of single-molecule sequencing – a valuable feature for a detailed characterization of the genome. To realize the potential of this platform, a number of groups that develop bioinformatics tools tuned to the unique characteristics of the data. We note that these development efforts will benefit from the software simulator, the output can be used to benchmark analysis tools.

Here, we introduce NanoSim, fast and scalable read simulator that captures a specific technology ONT data features and allows for adjustments to the improvement of nanopore sequencing technology. The first step is to read the NanoSim characterization, which provides a comprehensive analysis of the alignment-based and generates a set of read profile serves as the input for the next step, the simulation stage. Phase simulations using a model built in the previous step to generate in silico reading for a given reference genome. NanoSim written in Python and R.

Cancer of the bladder, 75 cases (1.1mm)

BLC1501 1
EUR 354
Description: Bladder cancer tissue array, 150 cores from normal, inflammatory (5 cases) and cancer (70 cases) tissues in duplicates, with grading and TNM staging data.

BLAP75 (RMI1) (NM_024945) Human Recombinant Protein

PROTQ9H9A7 20ug
EUR 1249
Description: Purified recombinant protein of Homo sapiens RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) (RMI1)

BLAP75 (RMI1) (NM_024945) Human Over-expression Lysate

LS080010 100ug
EUR 628
Description: Transient overexpression lysate of RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) (RMI1)

NubO (68–75), Ndufa4 (68–75)

5-01645 4 x 5mg Ask for price

PIK-75

202238 25.0mg
EUR 150

C 75

A4449-10 10 mg
EUR 251
Description: Fatty acid synthase (FAS) inhibitor

C 75

A4449-5 5 mg
EUR 152
Description: Fatty acid synthase (FAS) inhibitor

C 75

A4449-5.1 10 mM (in 1mL DMSO)
EUR 297.6
Description: C 75 is an inhibitor of fatty acid synthase [1]. Fatty acid synthase (FAS) is a multi-enzyme protein that catalyzes fatty acid synthesis. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA.

C 75

A4449-50 50 mg
EUR 1062
Description: Fatty acid synthase (FAS) inhibitor

PIK-75

A2080-10 10 mg
EUR 40
Description: Inhibitor of PI3K isoform p110α

PIK-75

A2080-100 100 mg
EUR 144
Description: Inhibitor of PI3K isoform p110α

PIK-75

A2080-5.1 10 mM (in 1mL DMSO)
EUR 49
Description: Inhibitor of PI3K isoform p110α

PIK-75

A2080-50 50 mg
EUR 104
Description: Inhibitor of PI3K isoform p110α

PIK-75

GW8870 1mg
EUR 162.19

PIK 75

MBS132168-100mg 100mg
EUR 1065

PIK 75

MBS132168-500mg 500mg
EUR 2775

PIK 75

MBS132430-100mg 100mg
EUR 1065

PIK 75

MBS132430-500mg 500mg
EUR 2775

PIK-75

GW8870-1 1
EUR 121.8

PIK-75

GW8870-10 10
EUR 163.2

PIK-75

GW8870-5 5
EUR 146.7

PIK-75

HY-13281 100mg
EUR 340.8

Oleuropein, 75%

O532950 10g
EUR 127
Description: 32619-42-4

Longifolene (>75%)

L469455 10g
EUR 97
Description: 475-20-7

Longipinene (~75%)

L469750 5mg
EUR 59
Description: 5989-08-2

Perfluorohexanesulfonamide (~75%)

P999355 100mg
EUR 65
Description: 41997-13-1

PIK-75

P437670 1mg
EUR 82

S 75

T34467-10mg 10mg Ask for price
Description: S 75

S 75

T34467-1g 1g Ask for price
Description: S 75

S 75

T34467-1mg 1mg Ask for price
Description: S 75

S 75

T34467-50mg 50mg Ask for price
Description: S 75

S 75

T34467-5mg 5mg Ask for price
Description: S 75

PIK-75

T2667-10mg 10mg Ask for price
Description: PIK-75

PIK-75

T2667-1g 1g Ask for price
Description: PIK-75

PIK-75

T2667-1mg 1mg Ask for price
Description: PIK-75

PIK-75

T2667-50mg 50mg Ask for price
Description: PIK-75

PIK-75

T2667-5mg 5mg Ask for price
Description: PIK-75

S 75

MBS5783973-5mg 5(mg
EUR 915

S 75

MBS5783973-5x5mg 5x5(mg
EUR 3970

PIK-75

MBS385954-100mg 100mg
EUR 260

PIK-75

MBS385954-10mg 10mg
EUR 130

PIK-75

MBS385954-25mg 25mg
EUR 160

PIK-75

MBS385954-50mg 50mg
EUR 210

PIK-75

MBS385954-5x100mg 5x100mg
EUR 1165

PIK-75

MBS3604286-100mg 100mg
EUR 310

PIK-75

MBS3604286-10mg 10mg
EUR 200

PIK-75

MBS3604286-200mg 200mg
EUR 440

PIK-75

MBS3604286-25mg 25mg
EUR 225

PIK-75

MBS3604286-50mg 50mg
EUR 260

PIK-75

MBS577166-100mg 100mg
EUR 240

PIK-75

MBS577166-10mg 10mg
EUR 140

PIK-75

MBS577166-200mg 200mg
EUR 375

PIK-75

MBS577166-25mg 25mg
EUR 160

PIK-75

MBS577166-50mg 50mg
EUR 195

PIK-75

HY-107834 Get quote Ask for price
Description: PIK-75 is a reversible DNA-PK and p110α-selective inhibitor, which inhibits DNA-PK, p110α and p110γ with IC50s of 2, 5.8 and 76 nM, respectively. PIK-75 inhibits p110α >200-fold more potently than p110β (IC50=1.3 μM)[1][2]. PIK-75 induces apoptosis[3].

NubO (68–75), Ndufa4 (68–75) Peptide

20-abx265976
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 mg
  • 25 mg
  • 5 mg

75 cm2 Nunc T-75 Flask Holder

LBI10238 each
EUR 235.44

NubO (68–75), Ndufa4 (68–75) Peptide

abx265976-100tests 100 tests
EUR 250

NubO (68–75), Ndufa4 (68–75) Peptide

abx265976-200tests 200 tests
EUR 337.5

NubO (68–75), Ndufa4 (68–75) Peptide

abx265976-500tests 500 tests
EUR 575

PTFE Stirrer Blade Plain End 75 x 25mm - EACH

STI4288 EACH
EUR 5.4

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (AP)

MBS6435714-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (AP)

MBS6435714-5x01mL 5x0.1mL
EUR 4120

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (PE)

MBS6435724-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (PE)

MBS6435724-5x01mL 5x0.1mL
EUR 4120

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (APC)

MBS6435715-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (APC)

MBS6435715-5x01mL 5x0.1mL
EUR 4120

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (FITC)

MBS6435717-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (FITC)

MBS6435717-5x01mL 5x0.1mL
EUR 4120

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (HRP)

MBS6435718-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (HRP)

MBS6435718-5x01mL 5x0.1mL
EUR 4120

b-Lapachone (90%)

L175300 50mg
EUR 58
Description: 4707-32-8

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (Biotin)

MBS6435716-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (Biotin)

MBS6435716-5x01mL 5x0.1mL
EUR 4120

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 405)

MBS6435719-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 405)

MBS6435719-5x01mL 5x0.1mL
EUR 4120

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 490)

MBS6435720-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 490)

MBS6435720-5x01mL 5x0.1mL
EUR 4120

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 550)

MBS6435721-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 550)

MBS6435721-5x01mL 5x0.1mL
EUR 4120

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 650)

MBS6435722-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 650)

MBS6435722-5x01mL 5x0.1mL
EUR 4120

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 750)

MBS6435723-01mL 0.1mL
EUR 950

RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 750)

MBS6435723-5x01mL 5x0.1mL
EUR 4120

75 cm2 BD/Greiner T-75 Flask Holder

LBI10240 each
EUR 418.56

Antileukoproteinase 1 (75-89) / SLPI (75-89) (Human)

002-97 100 μg
EUR 160.92

Musclin (39-75) / Osteocrin (Ostn) (39-75) (Mouse)

028-71 100 μg
EUR 282.96

Abietic Acid, 75%

A108200 100g
EUR 127
Description: 514-10-3

ZR-75-1

ABC-TC1310 1 vial Ask for price
Description: The cells produce high levels of MUC-1 mucin mRNA, low levels of MUC-2 mRNA but do not express the MUC-3 gene.

ZR-75-30

ABC-TC1311 1 vial Ask for price
Description: ZR-75-30 was derived from malignant ascites fluid from a 47-year-old premenopausal Black woman with infiltrating ductal carcinoma. These cells have been characterized to be human, non-HeLa, malignant mammary epithelium in origin.

PIK-75 HCl

408028 10.0mg
EUR 250

ND-75 Antibody

20-abx300635
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

ND-75 Antibody

1-CSB-PA821986LA01DLU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against ND-75. Recognizes ND-75 from Drosophila melanogaster. This antibody is Unconjugated. Tested in the following application: ELISA

Bacitracin F (~75%)

B106530 10mg
EUR 820
Description: 22601-63-4

1,2-Bismethylenecyclohexane (~75%)

B494805 100mg
EUR 1455
Description: 2819-48-9

Cytokeratin 75 antibody

70R-3038 50 ug
EUR 467
Description: Rabbit polyclonal Cytokeratin 75 antibody raised against the N terminal of KRT75

Cytokeratin 75 antibody

70R-3039 50 ug
EUR 467
Description: Rabbit polyclonal Cytokeratin 75 antibody raised against the middle region of KRT75

Allyl Mercaptan (>75%)

A614543 2.5g
EUR 68
Description: 870-23-5

D-Glucamine (>75%)

G413200 1g
EUR 108

Phorone 70-75%

P16690 1G
EUR 162.59

Potassium laurate 75%

P23250 5G
EUR 81.11

Selenomethionine Se 75

T34608-10mg 10mg Ask for price
Description: Selenomethionine Se 75

Selenomethionine Se 75

T34608-1g 1g Ask for price
Description: Selenomethionine Se 75

Selenomethionine Se 75

T34608-1mg 1mg Ask for price
Description: Selenomethionine Se 75

Selenomethionine Se 75

T34608-50mg 50mg Ask for price
Description: Selenomethionine Se 75

Selenomethionine Se 75

T34608-5mg 5mg Ask for price
Description: Selenomethionine Se 75

BU-E 75

T23835-10mg 10mg Ask for price
Description: BU-E 75

BU-E 75

T23835-1g 1g Ask for price
Description: BU-E 75

BU-E 75

T23835-1mg 1mg Ask for price
Description: BU-E 75

BU-E 75

T23835-50mg 50mg Ask for price
Description: BU-E 75

BU-E 75

T23835-5mg 5mg Ask for price
Description: BU-E 75

PIK-75 hydrochloride

T2287-10mg 10mg Ask for price
Description: PIK-75 hydrochloride

PIK-75 hydrochloride

T2287-1g 1g Ask for price
Description: PIK-75 hydrochloride

PIK-75 hydrochloride

T2287-1mg 1mg Ask for price
Description: PIK-75 hydrochloride

PIK-75 hydrochloride

T2287-50mg 50mg Ask for price
Description: PIK-75 hydrochloride

PIK-75 hydrochloride

T2287-5mg 5mg Ask for price
Description: PIK-75 hydrochloride

(-)-Tetrabenazine (>75% ee)

T284023 25mg
EUR 167

cdc25A (Ab-75)

ANTY021163 100ug
EUR 259

ND-75 Antibody

abx300635-100g 100 µg
EUR 362.5

ND-75 Antibody

abx300635-20g 20 µg
EUR 162.5

ND-75 Antibody

abx300635-50g 50 µg
EUR 250

Antitumor agent-75

T62510-10mg 10mg Ask for price
Description: Antitumor agent-75

Antitumor agent-75

T62510-1g 1g Ask for price
Description: Antitumor agent-75

Antitumor agent-75

T62510-1mg 1mg Ask for price
Description: Antitumor agent-75

Antitumor agent-75

T62510-50mg 50mg Ask for price
Description: Antitumor agent-75

Antitumor agent-75

T62510-5mg 5mg Ask for price
Description: Antitumor agent-75

Antibacterial agent 75

T61799-10mg 10mg Ask for price
Description: Antibacterial agent 75

Antibacterial agent 75

T61799-1g 1g Ask for price
Description: Antibacterial agent 75

Antibacterial agent 75

T61799-1mg 1mg Ask for price
Description: Antibacterial agent 75

Antibacterial agent 75

T61799-50mg 50mg Ask for price
Description: Antibacterial agent 75

Antibacterial agent 75

T61799-5mg 5mg Ask for price
Description: Antibacterial agent 75

Anticancer agent 75

T60998-10mg 10mg Ask for price
Description: Anticancer agent 75

Anticancer agent 75

T60998-1g 1g Ask for price
Description: Anticancer agent 75

Anticancer agent 75

T60998-1mg 1mg Ask for price
Description: Anticancer agent 75

Anticancer agent 75

T60998-50mg 50mg Ask for price
Description: Anticancer agent 75

Anticancer agent 75

T60998-5mg 5mg Ask for price
Description: Anticancer agent 75

Selenomethionine Se 75

MBS5784110-5mg 5(mg
EUR 915

Selenomethionine Se 75

MBS5784110-5x5mg 5x5(mg
EUR 3970

BU-E 75

MBS5773600-5mg 5(mg
EUR 915

BU-E 75

MBS5773600-5x5mg 5x5(mg
EUR 3970

ND-75 Antibody

MBS7000079-005mg 0.05mg
EUR 190

ND-75 Antibody

MBS7000079-01mg 0.1mg
EUR 270

ND-75 Antibody

MBS7000079-5x01mg 5x0.1mg
EUR 1205

NubO (68-75)

MBS8246840-10mg 10mg
EUR 560

NubO (68-75)

MBS8246840-1mg 1mg
EUR 225

NubO (68-75)

MBS8246840-5mg 5mg
EUR 400

NubO (68-75)

MBS8246840-5x10mg 5x10mg
EUR 2435

Cytokeratin 75 antibody

MBS839474-01mL 0.1mL
EUR 750

Cytokeratin 75 antibody

MBS839474-5x01mL 5x0.1mL
EUR 3215

C-75 Trans

MBS3841024-10mg 10mg
EUR 245

C-75 Trans

MBS3841024-50mg 50mg
EUR 810

C-75 Trans

MBS3841024-5mg 5mg
EUR 190

C-75 Trans

MBS3841024-5x50mg 5x50mg
EUR 3630

Cytokeratin 75 antibody

MBS5301122-01mL 0.1mL
EUR 750

Cytokeratin 75 antibody

MBS5301122-5x01mL 5x0.1mL
EUR 3215

Grp 75 Standard

MBS483003-03mL 0.3mL
EUR 285

Grp 75 Standard

MBS483003-5x03mL 5x0.3mL
EUR 1045

Sephadex G-75

Se-492C 100 g
EUR 992
Description: Chromatography Reagents

Sephadex G 75

PC2030-500 500mg
EUR 40

HSP 75 Antibody

C30876-100ul 100μl
EUR 217
Description: HSP 75 Rabbit Polyclonal Antibody

HSP 75 Antibody

C30876-50ul 50μl
EUR 143.5
Description: HSP 75 Rabbit Polyclonal Antibody

Superdex 75 Increase

Su-322P each
EUR 5440
Description: Chromatography Reagents

Antifungal agent 75

HY-156252 Get quote Ask for price
Description: Antifungal agent 75 (compound 6r) is a potent antifungal agent against Candida albicans. Antifungal agent 75 significantly inhibits the formation of C. albicans biofilm, increases the permeability of the cell membrane, reduces the ergosterol level of the cell membrane, damages the membrane structure, and destroys the integrity of the cell structure to exert excellent antifungal activity[1].

Antitumor agent-75

HY-151295 Get quote Ask for price
Description: Antitumor agent-75 is a novel potent antitumor agent. Antitumor agent-75 has cytotoxic effects on cancer and normal human cell lines. Antitumor agent-75 shows a highly selective cytotoxic effect against human lung adenocarcinoma (cell line A549) when combined with Antitumor agent-74 (HY-151292), the IC50 value of 2.8 μM. Antitumor agent-75 can be used for the research of cancer[1].

EGFR-IN-75

HY-152144 Get quote Ask for price
Description: EGFR-IN-75 is an EGFRWT and EGFRT790M inhibitor with IC50 values of 0.28 μM and 5.02 μM, respectively. EGFR-IN-75 shows anticancer and antioxidant activity[1].

Antibacterial agent 75

HY-144621 Get quote Ask for price
Description: Antibacterial agent 75 (compound 24) is an antibacterial agent. Antibacterial agent 75 (compound 24) is able to re-sensitize VRSA to vancomycin[1].

Anticancer agent 75

HY-147971 Get quote Ask for price
Description: Anticancer agent 75 is a potent anticancer agent. Anticancer agent 75 shows cytotoxicity and selectivity in cancer cell lines. Anticancer agent 75 shows cytotoxicity to normal human kidney cell lines is at least 35 times lower than that of the Doxorubicin standard. Anticancer agent 75 shows good activity of antiplasmodial[1].

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1158376-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1050

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1158376-002mgEColi 0.02mg(E-Coli)
EUR 635

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1158376-002mgYeast 0.02mg(Yeast)
EUR 805

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1158376-01mgEColi 0.1mg(E-Coli)
EUR 735

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1158376-01mgYeast 0.1mg(Yeast)
EUR 940

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1233273-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1050

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1233273-002mgEColi 0.02mg(E-Coli)
EUR 635

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1233273-002mgYeast 0.02mg(Yeast)
EUR 805

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1233273-01mgEColi 0.1mg(E-Coli)
EUR 735

Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75)

MBS1233273-01mgYeast 0.1mg(Yeast)
EUR 940

Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75)

MBS1281221-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1165

Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75)

MBS1281221-002mgEColi 0.02mg(E-Coli)
EUR 805

Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75)

MBS1281221-002mgYeast 0.02mg(Yeast)
EUR 955

Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75)

MBS1281221-01mgEColi 0.1mg(E-Coli)
EUR 965

Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75)

MBS1281221-01mgYeast 0.1mg(Yeast)
EUR 1120

Recombinant Alcelaphine herpesvirus 1 Probable membrane antigen 75 (75), partial

MBS1166158-INQUIRE INQUIRE Ask for price

Recombinant Saimiriine herpesvirus 2 Probable membrane antigen 75 (75), partial

MBS1216842-INQUIRE INQUIRE Ask for price

Musclin (39-75) / Osteocrin (Ostn) (39-75) (Mouse) - Biotin Labeled

B-028-71 10 μg
EUR 469.8

Musclin (39-75) / Osteocrin (Ostn) (39-75) (Mouse) - Cy3 Labeled

FC3-028-71 1 nmol
EUR 756

In this work, we model the basic error-call from ONT to read to inform simulation sequence with similar characteristics. We show the performance NanoSim on publicly available datasets generated using chemical R7.3 and R7 and different sequencing kit and compare the resulting synthetic sounds with other old-order simulator and experimental ONT read. We hope NanoSim have a role that allows the field and the benefits of the development of next-generation technology for nanopore sequencing scalable long reads, including genome assembly, mutation detection, and even a metagenomic analysis software.

Leave a Reply

Your email address will not be published.